Business Context and Reporting Period
This Form 6-K filing by Zhibao Technology Inc. covers the month of July 2026, with the report dated July 6, 2026. The filing primarily addresses significant changes to the Company's Board of Directors and principal officers, effective July 1, 2026.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The Company reported the following material changes to its leadership structure effective July 1, 2026:
- Resignations: Yuanwen Xia resigned as Director and Chief Financial Officer. Independent directors Armando Luis Baez, Stephen Bernardez, and Jeffery Rong Cai also resigned. The Board confirmed these departures were not due to any disagreement with the Company regarding operations, policies, or practices.
- Appointments:
- Guangtong Ren was appointed as Director and Chief Financial Officer.
- Jun Ma, YiYun Dai, and Han Tang were appointed as independent directors.
- Committee Assignments:
- Jun Ma: Chair of the Nominating and Corporate Governance Committee; member of Compensation and Audit Committees.
- YiYun Dai: Chair of the Audit Committee; member of Compensation and Nominating and Corporate Governance Committees.
- Han Tang: Chair of the Compensation Committee; member of Audit and Nominating and Corporate Governance Committees.
Management Commentary and Background
The filing provides detailed professional backgrounds for the newly appointed officers to justify their qualifications:
- Guangtong Ren (New CFO): Served as Chief Actuary since December 2025. Possesses over 25 years of experience in corporate finance, insurance, and risk management, including prior roles at AIG Insurance Company China Limited, Ping An Insurance, and GLP Capital Partners.
- Jun Ma (New Independent Director): Extensive healthcare management experience, including establishing an organ transplant ICU in China and serving as General Manager of Fanyi Health Corp. since November 2024.
- YiYun Dai (New Independent Director): Extensive experience in insurance and consulting, with prior leadership roles at Global Benefits Group China, Alltrust Insurance, and Chubb Insurance China.
- Han Tang (New Independent Director): Background in marketing and operations across consumer products and insurance, with prior experience at Willis Towers Watson and ADP China.
Key Facts for Investor Verification
- Verify the effective date of the leadership transition (July 1, 2026) and confirm the immediate operational impact of the CFO change.
- Confirm that the resignations of the previous CFO and three independent directors were indeed voluntary and unrelated to any undisclosed disputes.
- Review the Company's subsequent filings (e.g., Form 20-F) for financial data, as this Form 6-K contains no financial metrics.
- Assess the strategic fit of the new CFO's background in insurance and actuarial science relative to Zhibao Technology's core business model.